AtriCure Inc. (ATRC) PT Raised to $65 by Stifel - Physicians Favor LAAM Technology
Tweet Send to a Friend
Stifel analyst John McAulay reiterated a Buy rating and $65.00 price target on AtriCure Inc. (NASDAQ: ATRC).The analyst commented, "Since ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




